1-10 of 10
Fevzi Altuntas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Tolerability of BCMA-Directed mRNA CAR T-Cell Therapy in Multiple Myeloma and Autoimmune Disease

Milos D Miljkovic, Adam S. Asch, Gregory Orloff, Ralph Boccia, Jesús G Berdeja, Fevzi Altuntas, Stefan O. Ciurea, James F Howard, Jr., Tuan Vu, Bennett Myers, Nizar Chahin, Tahseen Mozaffar, Christopher M Jewell, Metin Kurtoglu
Journal: Blood
Blood (2024) 144 (Supplement 1): 2080.
https://doi.org/10.1182/blood-2024-203585
Published: 2024
Journal Articles

Odronextamab Monotherapy in Previously Untreated Patients with High-Risk Follicular Lymphoma (FL): Results of the Safety Lead-in of the Phase 3 Olympia-1 Study

Elizabeth Brem, Wojciech Jurczak, David Belada, Jaime Perez de Oteyza, Aranzazu Alonso Alonso, Fevzi Altuntas, Michał Kwiatek, Joshua Brody, Ernesto Perez Persona, Mustafa Yenerel, Monica Tani, Jingxian Cai, Priya Deshpande, Saleem Shariff, Aafia Chaudhry, Hesham Mohamed, Srikanth Ambati, Ashish Risal, Ruemu Birhiray
Journal: Blood
Blood (2024) 144 (Supplement 1): 4411.
https://doi.org/10.1182/blood-2024-200080
Published: 2024
Journal Articles

The Efficacy and Safety of Low-Dose Inotuzumab Ozogamicin in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia: Interim Results of a Phase 4 Study

Muhit Özcan, Ryan D. Cassaday, Pawan Singh, Ewa Zarzycka, Xin Zhang, Eric Nègre, Erik Vandendries, Fevzi Altuntas
Journal: Blood
Blood (2021) 138 (Supplement 1): 1208.
https://doi.org/10.1182/blood-2021-150001
Published: 2021
Journal Articles

Turkish Acute Lymphoblastic Leukemia Registry, Retrospective Phase Data

Fatih Demirkan, MD, Rafiye Ciftciler, MD, Omur Gokmen Sevindik, MD, Emre Tekgündüz, MD, Mehmet Ali Erkurt, MD, Filiz Vural, MD, Burhan Turgut, MD, Leylagul Kaynar, MD, Kadriye Bahriye Payzin, Mehmet Hilmi Dogu, MD, Volkan Karakus, MD, Fevzi Altuntas, MD, Yahya Buyukasik, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5073.
https://doi.org/10.1182/blood-2019-126006
Published: 2019
Journal Articles

A Multicenter Experience of Thrombotic Microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG) - TMA01 Study

Emre Tekgunduz, MD, Mehmet Yilmaz, MD, Mehmet Ali Erkurt, MD, Ilhami Kiki, MD, Ali Hakan Kaya, MD, Leylagul Kaynar, MD, Inci Alacacioglu, MD, Guven Cetin, MD, Ibrahim Ozarslan, MD, Irfan Kuku, MD, Gulden Sincan, MD, Ozan Salim, MD, Sinem Namdaroglu, MD, Abdullah Karakuş, MD, Volkan Karakuş, MD, Gulsum Emel Pamuk, MD, Fevzi Altuntas, MD, Hakan Ismail Sari, MD, Gulsum Ozet, MD, Ismet Aydogdu, MD, Vahap Okan, MD, Emin Kaya, MD, Rahsan Yildirim, MD, Esra Yildizhan, MD, Gokhan Ozgur, MD, Osman Ilhami Ozcebe, MD, Bahriye Payzin, MD, Seval Akpinar, MD, Fatih Demirkan, MD
Journal: Blood
Blood (2016) 128 (22): 4933.
https://doi.org/10.1182/blood.V128.22.4933.4933
Published: 2016
Journal Articles

Is It Time for Early Cessation of Empirical Antibiotherapy in Patients Presenting with Febrile Neutropenia? Preliminary Results of a Risk-Adapted Approach in a Hematology Clinic

Ali Hakan Kaya, MD, Emre Tekgunduz, MD, Filiz Bekdemir, MD, Hikmetullah Batgi, MD, Tugcenur Yigenoglu, MD, Bahar Uncu Ulu, MD, Bilge Ugur, MD, Dicle Iskender, MD, Merih Kizil Cakar, MD, Mehmet Sinan Dal, MD, Seval Akpinar, MD, Fatih Demirkan, MD, Fevzi Altuntas, MD
Journal: Blood
Blood (2016) 128 (22): 2503.
https://doi.org/10.1182/blood.V128.22.2503.2503
Published: 2016
Journal Articles

The Clinical Characteristics and Therapeutic Outcomes of Elderly Patients with Chronic Lymphocytic Leukemia: A Retrospective Multicenter Study

Anil Tombak, Naci Tiftik, Mehmet Hilmi Dogu, Ismail Sari, Meltem Olga Akay, Mustafa Karagulle, Emin Kaya, Serdal Korkmaz, Mehmet Sencan, Gulsah Akyol, Leylagul Kaynar, MD, Melda Comert, Guray Saydam, MD Prof, Sinan Mehmet Dal, Orhan M. Ayyildiz, MD Prof, Rahsan Yildirim, Ilhami Kiki, Erdal Kara, Ramazan Esen, Mehmet Ali Sungur, Mehmet Ali Erkurt, Fevzi Altuntas, Ali Unal, MD, Osman Ilhan, MD
Journal: Blood
Blood (2014) 124 (21): 5644.
https://doi.org/10.1182/blood.V124.21.5644.5644
Published: 2014
Journal Articles

Lower Doses of Plerixafor Use Is Sufficient to Effectively Mobilize PBSC (Peripheral Blood Hematopoetic Stem Cells) When Compared to Standard Administration

Hakan Goker, MD, Eylem Eliacik, MD, Fevzi Altuntas, MD, Emre Tekgunduz, MD, Evren Ozdemir, MD, Ayse Isik, MD, Omur Kayikci, MD, Ali Hakan Kaya, MD, Salih Aksu, MD, Ibrahim C. Haznedaroglu, MD, Nilgun Sayinalp, MD, Haluk Demiroglu, Osman Ilhami Ozcebe, MD, Yahya Buyukasik, MD
Journal: Blood
Blood (2014) 124 (21): 5830.
https://doi.org/10.1182/blood.V124.21.5830.5830
Published: 2014
Journal Articles

Effectiveness of Defibrotide in the Prevention of VOD Among Patients Receiving Allogeneic Hematopoetic Cell Transplantation: A Retrospective Single Center Experience

Emre Tekgunduz, MD, Seval Akpinar, Sinem Civriz Bozdag, MD, Aysegul Tetik, Serife Kocubaba, Murat Cinarsoy, Gamze Durgun, Sinem Namdaroglu, Omür Kayikci, Bilge Ugur, Itir Sirinoglu Demiriz, Fevzi Altuntas, MD
Journal: Blood
Blood (2012) 120 (21): 4508.
https://doi.org/10.1182/blood.V120.21.4508.4508
Published: 2012
Journal Articles

No Significant Expression of Wt1 Gene in Multiple Myeloma Patients at Diagnosis: Is Wt1 Gene Expression Useful Marker for Minimal Residual Disease in Multiple Myeloma?.

Yusuf Ozkul, PhD, Ahmet O. Caglayan, M.D., Ismail Kocyigit, M.D., Cetin Saatci, PhD., Hilal Akalin, Muzaffer Demir, M.D., Fevzi Altuntas, M.D., Mustafa Cetin, M.D., Bulent Eser, M.D., Leylagul Kaynar, PhD.
Journal: Blood
Blood (2007) 110 (11): 4761.
https://doi.org/10.1182/blood.V110.11.4761.4761
Published: 2007